Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

InVivoMAb Anti-HPV58 L1/Major capsid protein L1 (Iv0003)

Catalog #:   VVV19402 Specific References (110) DATASHEET
Host species: Human
Isotype: IgG1
Applications: ELISA, Neutralization
Accession: P26535
Overview

Catalog No.

VVV19402

Species reactivity

Human papillomavirus 58

Host species

Human

Isotype

IgG1

Clonality

Monoclonal

Target

Major capsid protein L1, L1

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P26535

Applications

ELISA, Neutralization

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

Iv0003

Data Image
  • SDS-PAGE
    SDS PAGE for HPV58 L1/Major capsid protein L1 (Iv0003)
References

Human Papillomavirus Vaccines. PMID: 34590141

The papillomavirus major capsid protein L1. PMID: 23800545

Identification of the mimotopes within the major capsid protein L1 of human papillomavirus types 18 and 45, using neutralizing monoclonal antibodies. PMID: 33493568

Human Papillomavirus Major Capsid Protein L1 Remains Associated with the Incoming Viral Genome throughout the Entry Process. PMID: 28566382

Characterization of major capsid protein (L1) variants of Human papillomavirus type 16 by cervical neoplastic status in Indian women: Phylogenetic and functional analysis. PMID: 31944308

Phylogeny and In Silico Structure Analysis of Major Capsid Protein (L1) Human Papillomavirus 45 from Indonesian Isolates. PMID: 32986347

Major findings and recent advances in virus-like particle (VLP)-based vaccines. PMID: 28887001

Expression of E4 Protein and HPV Major Capsid Protein (L1) as A Novel Combination in Squamous Intraepithelial Lesions. PMID: 36672733

Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. PMID: 1334560

[The soluble expression and application of human papillomavirus type 58 (HPV58) major capsid protein L1]. PMID: 35732612

Mapping the B cell epitopes within the major capsid protein L1 of human papillomavirus type 16. PMID: 29959021

Isoforms of the Papillomavirus Major Capsid Protein Differ in Their Ability to Block Viral Spread and Tumor Formation. PMID: 35359995

Optimized production strategy of the major capsid protein HPV 16L1 non-assembly variant in E. coli. PMID: 32681956

L2, the minor capsid protein of papillomavirus. PMID: 23689062

The Synthesis of Main Capsid Protein of Anogenital Type HPV6 L1 in Plant Expression System on the Basis of Tomato Fruits. PMID: 34189649

Protective immunity against Chlamydia trachomatis genital infection induced by a vaccine based on the major outer membrane multi-epitope human papillomavirus major capsid protein L1. PMID: 21324344

Naturally Occurring Capsid Protein Variants of Human Papillomavirus Genotype 31 Represent a Single L1 Serotype. PMID: 25995264

Genetic Diversity in the Major Capsid L1 Protein of HPV-16 and HPV-18 in the Netherlands. PMID: 27070907

Nuclear import strategies of high risk HPV16 L1 major capsid protein. PMID: 11971900

Production of human papillomavirus type 33 L1 major capsid protein and virus-like particles from Bacillus subtilis to develop a prophylactic vaccine against cervical cancer. PMID: 22305172

Genetic variability in the major capsid L1 protein of human papillomavirus type 16 (HPV-16) and 18 (HPV-18). PMID: 21729769

The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains. PMID: 9420209

Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses. PMID: 12050360

The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system. PMID: 9650960

The L1 major capsid protein of human papillomavirus type 11 interacts with Kap beta2 and Kap beta3 nuclear import receptors. PMID: 12620808

Human Papillomavirus Minor Capsid Protein L2 Mediates Intracellular Trafficking into and Passage beyond the Endoplasmic Reticulum. PMID: 35608352

Correction: Genetic Diversity in the Major Capsid L1 Protein of HPV-16 and HPV-18 in the Netherlands. PMID: 27123932

Prophylactic papillomavirus vaccines. PMID: 24559559

Simultaneous quantification of major capsid protein of human papillomavirus 16 and human papillomavirus 18 in multivalent human papillomavirus vaccines by liquid chromatography-tandem mass spectrometry. PMID: 32067760

Listeria monocytogenes delivery of HPV-16 major capsid protein L1 induces systemic and mucosal cell-mediated CD4+ and CD8+ T-cell responses after oral immunization. PMID: 19435416

[Production of HPV 16 major capsid protein L1 with baculovirus expression system]. PMID: 11986713

Observations on the expression of human papillomavirus major capsid protein in HeLa cells. PMID: 26064080

Dissection of Capsid Protein HPV 52 to Rationalize Vaccine Designs Using Computational Approaches Immunoinformatics and Molecular Docking. PMID: 35901328

The L1 major capsid protein of HPV16 differentially modulates APC trafficking according to the vaccination or natural infection context. PMID: 21061438

Virus-like Particle-Based L2 Vaccines against HPVs: Where Are We Today? PMID: 31877975

Papillomavirus-like particle vaccines. PMID: 11158207

Worldwide genetic variations in high-risk human papillomaviruses capsid L1 gene and their impact on vaccine efficiency. PMID: 33636291

The possible regions to design Human Papilloma Viruses vaccine in Iranian L1 protein. PMID: 32435064

Neutralization of human papillomavirus by specific nanobodies against major capsid protein L1. PMID: 22561868

Human papillomavirus vaccines. PMID: 11883690

Epitope design of L1 protein for vaccine production against Human Papilloma Virus types 16 and 18. PMID: 28584449

Increasing the expression levels of papillomavirus major capsid protein in Escherichia coli by N-terminal deletion. PMID: 17616400

Mutational analysis of human papillomavirus type 16 major capsid protein L1: the cysteines affecting the intermolecular bonding and structure of L1-capsids. PMID: 12706096

The C-Terminal Arm of the Human Papillomavirus Major Capsid Protein Is Immunogenic and Involved in Virus-Host Interaction. PMID: 27276427

Expression of codon optimized major capsid protein (L1) of human papillomavirus type 16 and 18 in Pichia pastoris; purification and characterization of the virus-like particles. PMID: 21803095

Assembly of the major and the minor capsid protein of human papillomavirus type 33 into virus-like particles and tubular structures in insect cells. PMID: 8178438

Critical Residues Involved in the Coassembly of L1 and L2 Capsid Proteins of Human Papillomavirus 16. PMID: 36815785

HPV DNA vaccines. PMID: 12456324

Evaluation of specific humoral and cellular immune responses against the major capsid L1 protein of cutaneous wart-associated alpha-Papillomaviruses in solid organ transplant recipients. PMID: 25439730

Expression of the human papillomavirus type 11 L1 capsid protein in Escherichia coli: characterization of protein domains involved in DNA binding and capsid assembly. PMID: 9060658

Cloning and Expression of L1 Protein Human Papillomavirus Type 31 Isolated from Iranian Patients in Escherichia coli. PMID: 27244269

Expression of the major capsid protein of human papillomavirus type 11 in Saccharomyces cerevisae. PMID: 8973339

The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes. PMID: 10026203

Naturally Occurring Single Amino Acid Substitution in the L1 Major Capsid Protein of Human Papillomavirus Type 16: Alteration of Susceptibility to Antibody-Mediated Neutralization. PMID: 28968823

Insights into the role and function of L2, the minor capsid protein of papillomaviruses. PMID: 19169853

Papillomavirus capsid protein expression in Escherichia coli: purification and assembly of HPV11 and HPV16 L1. PMID: 11243812

Cloning and expression of the L1 major capsid protein of the human papillomavirus 18 in murine cells. PMID: 14612984

Oral immunization with different assembly forms of the HPV 16 major capsid protein L1 induces neutralizing antibodies and cytotoxic T-lymphocytes. PMID: 17822733

Minor Capsid Protein L2 Polytope Induces Broad Protection against Oncogenic and Mucosal Human Papillomaviruses. PMID: 29212932

A Visual Discrimination of Existing States of Virus Capsid Protein by a Giant Molybdate Cluster. PMID: 35269224

Mutation Profile of HPV16 L1 and L2 Genes in Different Geographic Areas. PMID: 36680181

Topography of the Human Papillomavirus Minor Capsid Protein L2 during Vesicular Trafficking of Infectious Entry. PMID: 26246568

Carboxyl terminus of bovine papillomavirus type-1 L1 protein is not required for capsid formation. PMID: 8806558

Expression and characterization of HPV-16 L1 capsid protein in Pichia pastoris. PMID: 19756360

Characterization of neutralizing epitopes within the major capsid protein of human papillomavirus type 33. PMID: 17014700

Emerging human papillomavirus vaccines. PMID: 23163511

Reactivities of polyclonal and monoclonal antibodies raised to the major capsid protein of human papillomavirus type 16. PMID: 2543739

Human papillomavirus type 16 pseudovirions with few point mutations in L1 major capsid protein FG loop could escape actual or future vaccination for potential use in gene therapy. PMID: 24639327

Developments in L2-based human papillomavirus (HPV) vaccines. PMID: 27889616

Optimizing the secondary structure of human papillomavirus type 16 L1 mRNA enhances L1 protein expression in Saccharomyces cerevisiae. PMID: 20696192

Self-Assembling Plant-Derived Vaccines Against Papillomaviruses. PMID: 29869236

Epitope screening of the major capsid protein within grouper iridovirus of Taiwan and the immunoprotective effect with SWCNTs as the vaccine carrier. PMID: 34280519

Natural variants in the major neutralizing epitope of human papillomavirus minor capsid protein L2. PMID: 22961598

Stop codon mutagenesis for homogenous expression of human papillomavirus L1 protein in Escherichia coli. PMID: 28267627

The h4 coil surface region of human papillomavirus type 58 L1 virus-like particle serves as a potential location for presenting the RG1 epitope peptide., PMID:40170153

[The soluble expression and application of human papillomavirus type 58 (HPV58) major capsid protein L1]., PMID:35732612

Development of HPV58 type-specific antibodies and detection kit., PMID:35465823

Combined truncations at both N- and C-terminus of human papillomavirus type 58 L1 enhanced the yield of virus-like particles produced in a baculovirus system., PMID:34890711

Worldwide genetic variations in high-risk human papillomaviruses capsid L1 gene and their impact on vaccine efficiency., PMID:33636291

Comprehensive Assessment of the Antigenic Impact of Human Papillomavirus Lineage Variation on Recognition by Neutralizing Monoclonal Antibodies Raised against Lineage A Major Capsid Proteins of Vaccine-Related Genotypes., PMID:32967963

Impact of Naturally Occurring Variation in the Human Papillomavirus 58 Capsid Proteins on Recognition by Type-Specific Neutralizing Antibodies., PMID:29905865

Human papillomavirus 16L1-58L2 chimeric virus-like particles elicit durable neutralizing antibody responses against a broad-spectrum of human papillomavirus types., PMID:28968993

Crystal Structures of Two Immune Complexes Identify Determinants for Viral Infectivity and Type-Specific Neutralization of Human Papillomavirus., PMID:28951471

L1 and L2 gene polymorphisms in HPV-58 and HPV-33: implications for vaccine design and diagnosis., PMID:27717385

Epitomics: IgG-epitome decoding of E6, E7 and L1 proteins from oncogenic human papillomavirus type 58., PMID:27708433

Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles., PMID:27147749

Seroprevalence of 10 human papillomavirus types in the general rural population of Anyang, China: a cross-sectional study., PMID:25999521

Prevalence of human papillomavirus variants and genetic diversity in the L1 gene and long control region of HPV16, HPV31, and HPV58 found in North-East Brazil., PMID:25793187

Pre-clinical immunogenicity of human papillomavirus alpha-7 and alpha-9 major capsid proteins., PMID:25203446

Methylation of human papillomavirus-52 and -58 is a candidate biomarker in cervical neoplasia., PMID:23871162

Amino acid sequence diversity of the major human papillomavirus capsid protein: implications for current and next generation vaccines., PMID:23722024

Genetic variability in L1 and L2 genes of HPV-16 and HPV-58 in Southwest China., PMID:23372836

Codon optimization of the human papillomavirus type 58 L1 gene enhances the expression of soluble L1 protein in Saccharomyces cerevisiae., PMID:23183918

The production and immunogenicity of human papillomavirus type 58 virus-like particles produced in Saccharomyces cerevisiae., PMID:23124750

Hospital-based prevalence of high-risk cervical HPV types infecting the general population and female sex workers in Huzhou, China., PMID:23044007

Comparison of real-time multiplex human papillomavirus (HPV) PCR assays with the linear array HPV genotyping PCR assay and influence of DNA extraction method on HPV detection., PMID:21346041

Comparison of real-time multiplex human papillomavirus (HPV) PCR assays with INNO-LiPA HPV genotyping extra assay., PMID:21068278

T-cell response to human papillomavirus type 58 L1, E6, And E7 peptides in women with cleared infection, cervical intraepithelial neoplasia, or invasive cancer., PMID:20668141

Translational comparison of HPV58 long and short L1 mRNAs in yeast (Saccharomyces cerevisiae) cell-free system., PMID:20541117

Papillomavirus pseudovirions packaged with the L2 gene induce cross-neutralizing antibodies., PMID:20334659

Phylogeographic analysis of human papillomavirus 58., PMID:20016974

[Preparation and identification of type specific and conformation dependent HPV16 L1 protein monoclonal antibody.]., PMID:19961800

Development of prophylactic recombinant HPV58-attenuated Shigella live vector vaccine and evaluation of its protective efficacy and immunogenicity in the guinea pig keratoconjunctivitis model., PMID:19204831

Vaccination with HPV16 L2E6E7 fusion protein in GPI-0100 adjuvant elicits protective humoral and cell-mediated immunity., PMID:19095032

An optimized yeast cell-free system: sufficient for translation of human papillomavirus 58 L1 mRNA and assembly of virus-like particles., PMID:18691524

[Construction of prophylactic recombinant HPV58-attenuated Shigella vector live vaccine and evaluation of its protective efficacy and immunogenicity in the guinea pig keratoconjunctivitis model]., PMID:18062891

[Molecular detection of specific HPV types in Condylomata acuminata]., PMID:16257894

L1 sequence of a new human papillomavirus type-58 variant associated with cervical intraepithelial neoplasia., PMID:15665981

Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses., PMID:12050360

[Expression of the human papillomavirus type 58L1 capsid protein in E.coli and preparation of the HPV58 L1 mouse antiserum]., PMID:11986714

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1486

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

InVivoMAb Anti-HPV58 L1/Major capsid protein L1 (Iv0003) [VVV19402]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only